BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26255735)

  • 1. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
    Okafuji T; Okafuji T; Nakayama T
    Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HI antibody titer against rubella virus to determine the effect of mass vaccination in Tehran.
    Soleimanjahi H; Bamdad T; Fotouhi F; Roustai MH; Faghihzadeh S
    J Clin Virol; 2005 Oct; 34(2):153-4. PubMed ID: 16076562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
    Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
    Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental active and passive immunization against rubella.
    Budai J; Tóth M; Melis L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination with a live RA 27/3 strain rubella vaccine (Rudivax), a follow-up study.
    Suni JI; Meurman O; Hirvonen P; Vaheri A
    Vaccine; 1984 Dec; 2(4):281-3. PubMed ID: 6531969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on live rubella vaccine. IV. Comparative field trials with attenuated vaccines at different passage levels in Japanese quail embryo fibroblast cells.
    Minekawa Y; Suzuki N; Osame J; Ueda S; Yamanishi K
    Biken J; 1973 Dec; 16(4):155-60. PubMed ID: 4799207
    [No Abstract]   [Full Text] [Related]  

  • 10. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of rubella in northern Greece.
    Gioula G; Diza-Mataftsi E; Alexiou-Daniel S; Kyriazopoulou-Dalaina V
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):631-3. PubMed ID: 15243817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response in school children to live rubella vaccine (Cendehill strain).
    Iwakata S; Elkerton LE; Rhodes AJ; Bull JA; Labzoffsky NA
    Can Med Assoc J; 1972 May; 106(9):980-2. PubMed ID: 4554732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
    Hillary IB; Freestone DS
    J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on live rubella vaccine. 3. Field trials with vaccines attenuated by serial passages in primary pig kidney cells.
    Suzuki M; Minekawa Y; Osame J; Ueda S; Ogino T
    Biken J; 1973 Dec; 16(4):149-54. PubMed ID: 4799206
    [No Abstract]   [Full Text] [Related]  

  • 20. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
    Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.